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38.63(10.28)	 36.10(9.14)a	 41.13(10.91)b	 42.82(11.16)b	
Age	(Min,	
Max)	
21.26-63.91	 21.26-63.38	 21.44-63.91	 21.30-62.42	
%	Females	 89.12	 93.55	 84.44	 82.50	
%	Males	 10.88	 6.45	 15.56	 17.50	
Days,	Mean	
(SD)	
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1.92	(1.49)	 1.92	(1.52)a	 1.93	(1.44)a	 1.92(1.52)a	
25=<BMI	<	
30(%)	
10.99	 13.07	 11.24	 2.50	
30=<BMI<40(%)	 55.32	 56.21	 55.06	 52.50	


























































%	Weight	Loss	 Coefficient	 P-value	 95%	Conf.	
Interval	
No	Diabetes	 Reference	 	 	
Pre-Diabetes	 0.40	 0.501	 −0.76						1.56	
Diabetes	 −0.13	 0.873	 −1.71						1.46	
Age	(Years)	 −0.05	 0.036	 −0.11			−	0.004	
Male	 Reference	 	 	
Female	 0.95	 0.252	 −0.68						2.57	
Time	(Months)	 1.10	 0.003	 			0.38						0.82	




%	Weight	Loss	 Coefficient	 P-value	 95%	Conf.	
Interval	
No	Diabetes	 Reference	 	 	
Pre-Diabetes	 −0.20	 0.756	 −1.43						1.04	
Diabetes	 −0.44	 0.617	 −2.17						1.29	
Age	(Years)	 −0.05	 0.068	 −0.11						0.003	
Time	(Months)	 			1.24	 0.002	 −0.18				−0.0179	
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